世界のエピジェネティクス市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV11872)
◆英語タイトル:Global Epigenetics Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV11872
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:95
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはエピジェネティクスの世界市場について調査・分析した資料です。種類別(DNAメチル化、ヒストン修飾、その他技術)の市場規模、用途別(腫瘍、代謝性疾患、発生生物、免疫、心血管疾患、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別エピジェネティクスの競争状況、市場シェア
・世界のエピジェネティクス市場:種類別市場規模 2015年-2020年(DNAメチル化、ヒストン修飾、その他技術)
・世界のエピジェネティクス市場:種類別市場規模予測 2021年-2026年(DNAメチル化、ヒストン修飾、その他技術)
・世界のエピジェネティクス市場:用途別市場規模 2015年-2020年(腫瘍、代謝性疾患、発生生物、免疫、心血管疾患、その他)
・世界のエピジェネティクス市場:用途別市場規模予測 2021年-2026年(腫瘍、代謝性疾患、発生生物、免疫、心血管疾患、その他)
・北米のエピジェネティクス市場分析:米国、カナダ
・ヨーロッパのエピジェネティクス市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのエピジェネティクス市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のエピジェネティクス市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのエピジェネティクス市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):IlluminA、Thermo Fisher Scientific、Merck Millipore、Abcam、Active Motif、Bio-Rad、New England Biolabs、Agilent、Qiagen、Zymo ResearcH、Perkinelmer、Diagenode
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Based on product, the global market for epigenetics, is segmented into enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. In 2017, the kits segment accounted for the largest share of global market for epigenetics. The large share of this segment is attributed to the fact that a large number of kits are used in epigenetic techniques. The rising prevalence of a number of diseases, increasing R&D spending, and increased government funding for life science research are the other factors supporting market growth.
Market growth can be attributed to the decreasing sequencing costs, increase in research activities, availability of funding for epigenetics research, and rising prevalence of cancer.

Market Analysis and Insights: Global Epigenetics Market
The global Epigenetics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of 4.8%% during 2021-2026.

Global Epigenetics Scope and Market Size
Epigenetics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Epigenetics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
IlluminA
Thermo Fisher Scientific
Merck Millipore
Abcam
Active Motif
Bio-Rad
New England Biolabs
Agilent
Qiagen
Zymo ResearcH
Perkinelmer
Diagenode

Market segment by Type, the product can be split into
DNA Methylation
Histone Modifications
Other Technologies
Market segment by Application, split into
Oncology
Metabolic Diseases
Developmental Biology
Immunology
Cardiovascular Diseases
Other Applications

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Epigenetics Revenue
1.4 Market by Type
1.4.1 Global Epigenetics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 DNA Methylation
1.4.3 Histone Modifications
1.4.4 Other Technologies
1.5 Market by Application
1.5.1 Global Epigenetics Market Share by Application: 2020 VS 2026
1.5.2 Oncology
1.5.3 Metabolic Diseases
1.5.4 Developmental Biology
1.5.5 Immunology
1.5.6 Cardiovascular Diseases
1.5.7 Other Applications
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Epigenetics Market Perspective (2015-2026)
2.2 Global Epigenetics Growth Trends by Regions
2.2.1 Epigenetics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Epigenetics Historic Market Share by Regions (2015-2020)
2.2.3 Epigenetics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Epigenetics Market Growth Strategy
2.3.6 Primary Interviews with Key Epigenetics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Epigenetics Players by Market Size
3.1.1 Global Top Epigenetics Players by Revenue (2015-2020)
3.1.2 Global Epigenetics Revenue Market Share by Players (2015-2020)
3.1.3 Global Epigenetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Epigenetics Market Concentration Ratio
3.2.1 Global Epigenetics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Epigenetics Revenue in 2019
3.3 Epigenetics Key Players Head office and Area Served
3.4 Key Players Epigenetics Product Solution and Service
3.5 Date of Enter into Epigenetics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Epigenetics Historic Market Size by Type (2015-2020)
4.2 Global Epigenetics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Epigenetics Market Size by Application (2015-2020)
5.2 Global Epigenetics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Epigenetics Market Size (2015-2020)
6.2 Epigenetics Key Players in North America (2019-2020)
6.3 North America Epigenetics Market Size by Type (2015-2020)
6.4 North America Epigenetics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Epigenetics Market Size (2015-2020)
7.2 Epigenetics Key Players in Europe (2019-2020)
7.3 Europe Epigenetics Market Size by Type (2015-2020)
7.4 Europe Epigenetics Market Size by Application (2015-2020)

8 China
8.1 China Epigenetics Market Size (2015-2020)
8.2 Epigenetics Key Players in China (2019-2020)
8.3 China Epigenetics Market Size by Type (2015-2020)
8.4 China Epigenetics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Epigenetics Market Size (2015-2020)
9.2 Epigenetics Key Players in Japan (2019-2020)
9.3 Japan Epigenetics Market Size by Type (2015-2020)
9.4 Japan Epigenetics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Epigenetics Market Size (2015-2020)
10.2 Epigenetics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Epigenetics Market Size by Type (2015-2020)
10.4 Southeast Asia Epigenetics Market Size by Application (2015-2020)

11 India
11.1 India Epigenetics Market Size (2015-2020)
11.2 Epigenetics Key Players in India (2019-2020)
11.3 India Epigenetics Market Size by Type (2015-2020)
11.4 India Epigenetics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Epigenetics Market Size (2015-2020)
12.2 Epigenetics Key Players in Central & South America (2019-2020)
12.3 Central & South America Epigenetics Market Size by Type (2015-2020)
12.4 Central & South America Epigenetics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 IlluminA
13.1.1 IlluminA Company Details
13.1.2 IlluminA Business Overview
13.1.3 IlluminA Epigenetics Introduction
13.1.4 IlluminA Revenue in Epigenetics Business (2015-2020))
13.1.5 IlluminA Recent Development
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Details
13.2.2 Thermo Fisher Scientific Business Overview
13.2.3 Thermo Fisher Scientific Epigenetics Introduction
13.2.4 Thermo Fisher Scientific Revenue in Epigenetics Business (2015-2020)
13.2.5 Thermo Fisher Scientific Recent Development
13.3 Merck Millipore
13.3.1 Merck Millipore Company Details
13.3.2 Merck Millipore Business Overview
13.3.3 Merck Millipore Epigenetics Introduction
13.3.4 Merck Millipore Revenue in Epigenetics Business (2015-2020)
13.3.5 Merck Millipore Recent Development
13.4 Abcam
13.4.1 Abcam Company Details
13.4.2 Abcam Business Overview
13.4.3 Abcam Epigenetics Introduction
13.4.4 Abcam Revenue in Epigenetics Business (2015-2020)
13.4.5 Abcam Recent Development
13.5 Active Motif
13.5.1 Active Motif Company Details
13.5.2 Active Motif Business Overview
13.5.3 Active Motif Epigenetics Introduction
13.5.4 Active Motif Revenue in Epigenetics Business (2015-2020)
13.5.5 Active Motif Recent Development
13.6 Bio-Rad
13.6.1 Bio-Rad Company Details
13.6.2 Bio-Rad Business Overview
13.6.3 Bio-Rad Epigenetics Introduction
13.6.4 Bio-Rad Revenue in Epigenetics Business (2015-2020)
13.6.5 Bio-Rad Recent Development
13.7 New England Biolabs
13.7.1 New England Biolabs Company Details
13.7.2 New England Biolabs Business Overview
13.7.3 New England Biolabs Epigenetics Introduction
13.7.4 New England Biolabs Revenue in Epigenetics Business (2015-2020)
13.7.5 New England Biolabs Recent Development
13.8 Agilent
13.8.1 Agilent Company Details
13.8.2 Agilent Business Overview
13.8.3 Agilent Epigenetics Introduction
13.8.4 Agilent Revenue in Epigenetics Business (2015-2020)
13.8.5 Agilent Recent Development
13.9 Qiagen
13.9.1 Qiagen Company Details
13.9.2 Qiagen Business Overview
13.9.3 Qiagen Epigenetics Introduction
13.9.4 Qiagen Revenue in Epigenetics Business (2015-2020)
13.9.5 Qiagen Recent Development
13.10 Zymo ResearcH
13.10.1 Zymo ResearcH Company Details
13.10.2 Zymo ResearcH Business Overview
13.10.3 Zymo ResearcH Epigenetics Introduction
13.10.4 Zymo ResearcH Revenue in Epigenetics Business (2015-2020)
13.10.5 Zymo ResearcH Recent Development
13.11 Perkinelmer
10.11.1 Perkinelmer Company Details
10.11.2 Perkinelmer Business Overview
10.11.3 Perkinelmer Epigenetics Introduction
10.11.4 Perkinelmer Revenue in Epigenetics Business (2015-2020)
10.11.5 Perkinelmer Recent Development
13.12 Diagenode
10.12.1 Diagenode Company Details
10.12.2 Diagenode Business Overview
10.12.3 Diagenode Epigenetics Introduction
10.12.4 Diagenode Revenue in Epigenetics Business (2015-2020)
10.12.5 Diagenode Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

IlluminA、Thermo Fisher Scientific、Merck Millipore、Abcam、Active Motif、Bio-Rad、New England Biolabs、Agilent、Qiagen、Zymo ResearcH、Perkinelmer、Diagenode

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のエピジェネティクス市場2026:インサイト・予測(Global Epigenetics Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。